Related Experiment Videos
Toxicity to bilirubin in neonates: infant development during first year in relation to maximum neonatal serum
Insights
High bilirubin levels in newborns are linked to lower motor scores and developmental delays in infants. This association is particularly strong in premature infants, impacting long-term neurologic development.
Area of Science:
- Neonatal Medicine
- Developmental Pediatrics
- Neuroscience
Background:
- Neonatal hyperbilirubinemia, characterized by elevated serum bilirubin levels, is a common condition in newborns.
- The potential long-term neurodevelopmental effects of hyperbilirubinemia, especially at moderate levels, require further investigation.
- Understanding these effects is crucial for timely intervention and improved infant outcomes.
Purpose of the Study:
- To investigate the correlation between maximum neonatal serum bilirubin levels and neurologic/developmental performance in the first year of life.
- To analyze this relationship across different racial groups and birth weight/gestational age categories.
- To determine if hyperbilirubinemia is an independent risk factor for developmental delays.
Main Methods:
- Utilized data from 27,000 infants in the Collaborative Perinatal Project.
- Correlated maximum neonatal serum bilirubin levels with infant neurologic and developmental assessments at 8 months and 1 year.
- Controlled for confounding factors including race, birth weight, and gestational age.
Main Results:
- Serum bilirubin levels of 10-14 mg/dl and above were associated with lower mean 8-month motor scores.
- Higher bilirubin levels correlated with delayed 1-year motor development.
- The association between hyperbilirubinemia and developmental outcomes was most pronounced in low-birth-weight/short-gestational-period infants.
- This relationship persisted even after accounting for variations in maturity within birth weight/gestational age groups.
Conclusions:
- Neonatal hyperbilirubinemia is associated with adverse neurologic and developmental outcomes in the first year of life.
- The impact of elevated bilirubin levels on development is significant, particularly for vulnerable infant populations.
- These findings underscore the importance of monitoring and managing neonatal jaundice to mitigate potential long-term developmental consequences.
Abstract:
Neurologic and developmental performance during the first year of life was correlated with maximum neonatal serum bilirubin levels for 27,000 infants in the Collaborative Perinatal Project. The infants were grouped by race and by five birth weight/gestational age categories to control for the effect of these factors on hyperbilirubinemia and developmental outcome. Low mean eight-month motor scores and delayed one-year motor development were associated with serum bilirubin levels in the range of 10 to 14 mg/dl and above. This relationship was strongest for low-birth-weight/short-gestational-period infants. A persistent association of developmental outcome with hyperbilirubinemia was found over and above the variation of maturity within the birth weight/gestational age categories.